Cimetidine 800 mg twice daily for healing erosions and ulcers in gastroesophageal reflux disease

Journal of Clinical Gastroenterology

Volumn 12, Issue , 1990, Pages S29-S34

  Palmer, Robert H ^a   Frank, William O ^a   Rockhold, Frank W ^a   Wetherington, Jeffrey D ^a   Young, Michael D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cimetidine; Gastroesophageal reflux; GERD; Healing; Heartburn relief

Indexed keywords

CIMETIDINE;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; ESOPHAGUS ULCER; GASTROESOPHAGEAL REFLUX; HEALING; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CIMETIDINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MALE; MIDDLE AGE; STOMACH ULCER;

EID: 0025011956     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/00004836-199000000-00006     Document Type: Article

References (13)

1. Goyal RK. Diseases of the esophagus. In: Braun wald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, eds. Harrison’s principles of internal medicine, 1 lth edition. New York: McGraw-Hill, 1987:1231-9.
2. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-12.
3. Fink SM, McCallum RW. The role of prolonged esophageal pH monitoring in the diagnosis of gastroesophageal reflux. JAMA 1984;252:1160-4.
4. Koch GG, Landis JR, Freeman JL, Freeman DH Jr, Lehnen RG. A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics 1977;33:133-58.
5. Conover WJ, Iman RL. Rank transformations as a bridge between parametric and non-parametric statistics. Am Statist 1981;35:124-58.
6. Douglas WW. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Gilman AG, Goodman LS, Rail TW, Murad F, eds. Goodman and Gilman’s the pharmacological basis of therapeutics, 7th edition. New York: MacMillan Publishing Company, 1985:605-38.
7. DeVault KR, Castell DO. Effects of antireflux therapies on salivary function in normal humans. Dig Dis Sci 1987;32:603-8.
8. Marietta F, Monello S, Mandata ML, Sala LO, Blasi A. Effect of Cimetidine on lower esophageal sphincter pressure in normal subjects and in patients with gastroesophageal reflux. Gastroenterol Endosc 1979;2:27-30.
9. Siewert R, Lepsien G, Arnold R, Creutzfeldt W. Effect of Cimetidine on lower esophageal sphincter pressure, intragastric pH and serum levels of immunoreactive gastrin in man. Digestion 1977;15:81-5.
10. 2-receptor antagonists on gastric emptying. Gastroenterology 1977;72:9-13.
11. Sontag S, Robinson M, McCalluns RW, et al. Ranitidine therapy for gastroesophageal reflux disease results of a large double-blind trial. Arch Intern Med 1987;147:1485-91.
12. Frank WO, Wetherington J, Palmer RH, Young MD. Cimetidine-effective therapy for reflux esophagitis. Gastroenterology 1989;96:A156.
13. Karnes WE, Walsh JH. The gastrin hypothesis: implications for antisecretory drug selection. J Clin Gastroenterol 1990;12(suppl 2):S7-12 (this issue).